Not Yet RecruitingNot Applicable

Knowledge and Intentions of French Adults Regarding Abusive Head Trauma in Infants: An Online Survey

3,200 participantsStarted 2026-09-01

Plain-language summary

Abusive head trauma (AHT) is a leading cause of infant mortality and long-term neurodevelopmental disability, yet existing prevention programmes have shown limited effectiveness in reducing its incidence. This may reflect insufficient understanding of upstream determinants of behaviour, including population-level knowledge of AHT. This cross-sectional online study aims to assess AHT-related knowledge, behavioural intentions, and their determinants in a sample representative of the French adult population aged 18-80 years. Participants will be recruited through a quota-based online panel and social media. Participants will complete a standardised procedure including exposure to short videos depicting either a shaking gesture (dangerous) or non-dangerous infant-handling behaviors (playing, rocking), followed by questionnaires assessing interpretation of the gesture, knowledge of its consequences, and AHT-related knowledge. After standardised information on AHT is provided, behavioral intentions and theoretical knowledge will be reassessed. This study will provide the first nationally representative data on AHT-related knowledge in France and inform the development of targeted, evidence-based prevention strategies.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (any gender) between 18-80 years * Living in France * Fluent in French Exclusion Criteria: * Non-French speakers, as the questionnaire is only available in French * Refusal to participate in the research

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Proportion of correct answers

Timeframe: At baseline

Trial details

NCT IDNCT07735780

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-30

Contact for this trial

Enora Le ROUX, PhD

+ 33 1 40 03 23 66 enora.leroux@aphp.fr

View on ClinicalTrials.gov More Abusive Head Trauma trials